premenstrual syndrome.
Conditions
Interventions
Intervention 1: Intervention group: Modified intermittent fasting comprises one day of 75% caloric restriction and then eating a diet that provides 100% of their energy needs on the next day and follo
Sponsors
Kashan University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: Women in the age range of 18 to 50 years Their body mass index is more than or equal to 25 and less than 40 Menstrual bleeding lasting between 3 and 8 days, and normal menstrual cycles of 21–35 days Having PMS based on PSST (premenstrual symptoms screening tool) To comply with the study methods
Exclusion criteria
Exclusion criteria: Pregnancy Breastfeeding A history of any chronic diseases such as hypertension, heart disease, diabetes, gastrointestinal disorders such as gastritis, gastric and duodenal ulcers The habit of smoking Alcohol abuse Weight loss of more than1 to 2 kg in the past month Adherence to a special diet, and medication use in the last 2 months Taking dietary supplements to lose weight Mental or psychiatric disorders such as depression Clinically diagnosed diseases such as infectious, cancer, kidney, CVD, liver, neurological, endocrine, and gynecological diseases Having surgery in the last 6 months Enduring extreme stress during the trial Taking antidepressants and contraceptives Taking B6 supplements in the past 3 months Not completing the questionnaire for 3 successive days and 5 non-successive days
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The severity of PMS. Timepoint: Beginning and end of the study. Method of measurement: Calendar of Premenstrual syndrome Experiences (COPE).;Health-related Quality of Life. Timepoint: Beginning and end of the study. Method of measurement: SF-12 questionnaire.;Body mass index. Timepoint: Beginning and end of the study. Method of measurement: Weight: scale, height: stadiometer.;Free fat mass. Timepoint: Beginning and end of the study. Method of measurement: Inbody device.;Body fat mass. Timepoint: Beginning and end of the study. Method of measurement: Inbody device.;Waist circumference. Timepoint: Beginning and end of the study. Method of measurement: non-stretchable measuring tape.;The waist-to-hip ratio. Timepoint: Beginning and end of the study. Method of measurement: By dividing the waist circumference by the hip circumference. | — |
Secondary
| Measure | Time frame |
|---|---|
| Skeletal muscle mass. Timepoint: At the beginning and end of the study. Method of measurement: Inbody device.;Percent body fat. Timepoint: At the beginning and end of the study. Method of measurement: Inbody device.;The hip circumference. Timepoint: At the beginning and end of the study. Method of measurement: non-stretchable measuring tape.;Visceral fat area. Timepoint: At the beginning and end of the study. Method of measurement: Inbody device. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSaeedeh Hosseini Hooshiar
Kashan University of Medical Sciences
Outcome results
None listed